Combinations of ketamine and atropine are neuroprotective and reduce neuroinflammation after a toxic status epilepticus in mice

Toxicology and Applied Pharmacology

Volumn 259, Issue 2, 2012, Pages 195-209

  Dhote, Franck ^a   Carpentier, Pierre ^a   Barbier, Laure ^a   Peinnequin, André ^a   Baille, Valérie ^a   Pernot, Fabien ^a   Testylier, Guy ^a   Beaup, Claire ^a   Foquin, Annie ^a   Dorandeu, Fréderic ^a,b  

^a CENTRE DE RECHERCHES   (France)

^b Ecole du Val de Grace   (France)

Author keywords

Astroglia; Brain cytokines; Ketamine; Microglia; Neutrophil granulocytes; Soman; Status epilepticus

Indexed keywords

ATROPINE; KETAMINE; MESSENGER RNA; NEUROPROTECTIVE AGENT; SOMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ENCEPHALITIS; EPILEPTIC STATE; GLIA CELL; HIPPOCAMPUS; MALE; MOUSE; NEUROPROTECTION; NEUTROPHIL; NONHUMAN; PROTEIN CONTENT; TREATMENT OUTCOME; WEIGHT REDUCTION;

ANIMALS; AREA UNDER CURVE; ATROPINE; BRAIN; CHEMICAL WARFARE AGENTS; CHEMOKINE CCL5; CHEMOKINE CXCL1; EXCITATORY AMINO ACID ANTAGONISTS; KETAMINE; MALE; MICE; MUSCARINIC ANTAGONISTS; NEUROGLIA; NEUTROPHILS; POLYMERASE CHAIN REACTION; RANDOM ALLOCATION; RNA, MESSENGER; SOMAN; STATUS EPILEPTICUS;

CAVIA; MUS;

EID: 84857232188     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2011.12.024     Document Type: Article

References (104)

1. Adams S.D., Radhakrishnan R.S., Helmer K.S., Mercer D.W. Effects of anesthesia on lipopolysaccharide-induced changes in serum cytokines. J. Trauma 2008, 65:170-174.
2. Allan S.M., Tyrrell P.J., Rothwell N.J. Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 2005, 5:629-640.
3. Aroniadou-Anderjaska V., Figueiredo T.H., Apland J.P., Qashu F., Braga M.F. Primary brain targets of nerve agents: the role of the amygdala in comparison to the hippocampus. Neurotoxicology 2009, 30:772-776.
4. Avignone E., Ulmann L., Levavasseur F., Rassendren F., Audinat E. Status epilepticus induces a particular microglial activation state characterized by enhanced purinergic signaling. J. Neurosci. 2008, 28:9133-9144.
5. Babcock A.A., Kuziel W.A., Rivest S., Owens T. Chemokine expression by glial cells directs leukocytes to sites of axonal injury in the CNS. J. Neurosci. 2003, 23:7922-7930.
6. Baille V., Clarke P.G.H., Brochier G., Dorandeu F., Verna J.M., Four E., Lallement G., Carpentier P. Soman-induced convulsions: the neuropathology revisited. Toxicology 2005, 215:1-24.
7. Baille-Le Crom V., Collombet J.M., Carpentier P., Brochier G., Burckhart M.F., Foquin A., Pernot-Marino I., Rondouin G., Lallement G. Early regional changes of GFAP mRNA in rat hippocampus and dentate gyrus during soman-induced seizures. Neuroreport 1995, 7:365-369.
8. Bernardino L., Xapelli S., Silva A.P., Jakobsen B., Poulsen F.R., Oliveira C.R., Vezzani A., Malva J.O., Zimmer J. Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures. J. Neurosci. 2005, 25:6734-6744.
9. Bonni A., Sun Y., Nadal-Vicens M., Bhatt A., Frank D.A., Rozovsky I., Stahl N., Yancopoulos G.D., Greenberg M.E. Regulation of gliogenesis in the central nervous system by the JAK-STAT signaling pathway. Science 1997, 278:477-483.
10. Borges K., McDermott D., Irier H., Smith Y., Dingledine R. Degeneration and proliferation of astrocytes in the mouse dentate gyrus after pilocarpine-induced status epilepticus. Exp. Neurol. 2006, 201:416-427.
11. Braitman D.J., Sparenborg S. MK-801 protects against seizures induced by the cholinesterase inhibitor soman. Brain Res. Bull. 1989, 23:145-148.
12. Carballo E., Lai W.S., Blackshear P.J. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 1998, 281:1001-1005.
13. Carnevalli L.S., Pereira C.M., Jaqueta C.B., Alves V.S., Paiva V.N., Vattem K.M., Wek R.C., Mello L.E., Castilho B.A. Phosphorylation of the alpha subunit of translation initiation factor-2 by PKR mediates protein synthesis inhibition in the mouse brain during status epilepticus. Biochem. J. 2006, 397:187-194.
14. Carpentier P., Delamanche I.S., Le-Bert M., Blanchet G., Bouchaud C. Seizure-related opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats. Neurotoxicology 1990, 11:493-508.
15. Carpentier P., Foquin-Tarricone A., Bodjarian N., Rondouin G., Lerner-Natoli M., Kamenka J.M., Blanchet G., Denoyer M., Lallement G. Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning. Neurotoxicology 1994, 15:837-851.
16. Carpentier P., Foquin A., Rondouin G., Lerner-Natoli M., de Groot D.M.G., Lallement G. Effects of atropine sulphate on seizure activity and brain damage produced by soman in guinea-pigs: ECoG correlates of neuropathology. Neurotoxicology 2000, 21:521-540.
17. Carpentier P., Testylier G., Baille V., Dhote F., Job A., Pouyatos B., Pernot F., Foquin A., Delacour C., Hamilton M., Dorandeu F. Soman-induced seizures and related brain damage: how to treat seizures and assess their effects non-invasively?. J. Med. CBR Def. 2008, 6.
18. Chakfe Y., Seguin R., Antel J.P., Morissette C., Malo D., Henderson D., Seguela P. ADP and AMP induce interleukin-1beta release from microglial cells through activation of ATP-primed P2X7 receptor channels. J. Neurosci. 2002, 22:3061-3069.
19. Chavarria A., Alcocer-Varela J. Is damage in central nervous system due to inflammation?. Autoimmun. Rev. 2004, 3:251-260.
20. Chen J.W., Wasterlain C.G. Status epilepticus: pathophysiology and management in adults. Lancet Neurol. 2006, 5:246-256.
21. Churchill L., Pazdernik T.L., Jackson J.L., Nelson S.R., Samson F.E., McDonough J.H., McLeod C.G. Soman-induced brain lesions demonstrated by muscarinic receptor autoradiography. Neurotoxicology 1985, 6:81-90.
22. Collombet J.M., Four E., Bernabe D., Masqueliez C., Burckhart M.F., Baille V., Baubichon D., Lallement G. Soman poisoning increases neural progenitor proliferation and induces long-term glial activation in mouse brain. Toxicology 2005, 208:319-334.
23. Croker B.A., Krebs D.L., Zhang J.-G., Wormald S., Willson T.A., Stanley E.G., Robb L., Greenhalgh C.J., Forster I., Clausen B.E., Nicola N.A., Metcalf D., Hilton D.J., Roberts A.W., Alexander W.S. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 2003, 4:540-545.
24. De Simoni M.G., Perego C., Ravizza T., Moneta D., Conti M., Marchesi F., De Luigi A., Garattini S., Vezzani A. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur. J. Neurosci. 2000, 12:2623-2633.
25. Deng X.-H., Bertini G., Xu Y.-Z., Yan Z., Bentivoglio M. Cytokine-induced activation of glial cells in the mouse brain is enhanced at an advanced age. Neuroscience 2006, 141:645-661.
26. Dhote F., Peinnequin A., Carpentier P., Baille V., Delacour C., Foquin A., Lallement G., Dorandeu F. Prolonged inflammatory gene response following soman-induced seizures in mice. Toxicology 2007, 238:166-176.
27. Dillman J.F., Phillips C.S., Kniffin D.M., Tompkins C.P., Hamilton T.A., Kan R.K. Gene expression profiling of rat hippocampus following exposure to the acetylcholinesterase inhibitor soman. Chem. Res. Toxicol. 2009, 22:633-638.
28. Dorandeu F., Carpentier P., Baubichon D., Four E., Bernabe D., Burckhart M.F., Lallement G. Efficacy of the ketamine-atropine combination in the delayed treatment of soman-induced status epilepticus. Brain Res. 2005, 1051:164-175.
29. Dorandeu F., Baille V., Mikler J., Testylier G., Lallement G., Sawyer T., Carpentier P. Protective effects of S(+) ketamine and atropine against lethality and brain damage during soman-induced status epilepticus in guinea-pigs. Toxicology 2007, 234:185-193.
30. Dorandeu F., Carpentier P., Baille-Le Crom V., Dhote F., Testylier G., Pernot F., Mion G., Ruttimann M., Lallement G. Field treatment of soman-induced self-sustaining status epilepticus. Are ketamine and other NMDA antagonists the only options?. The Neurochemical Consequences of Organophosphate Poisoning in the CNS 2010, 149-183. Transworld Research Network Kerala, India. B. Weissman, L. Raveh (Eds.).
31. Fabene P.F., Navarro M.G., Martinello M., Rossi B., Merigo F., Ottoboni L., Bach S., Angiari S., Benati D., Chakir A., Zanetti L., Schio F., Osculati A., Marzola P., Nicolato E., Homeister J.W., Xia L., Lowe J.B., McEver R.P., Osculati F., Sbarbati A., Butcher E.C., Constantin G. A role for leukocyte-endothelial adhesion mechanisms in epilepsy. Nat. Med. 2008, 14:1377-1383.
32. Farber K., Kettenmann H. Physiology of microglial cells. Brain Res. Rev. 2005, 48:133-143.
33. Feinstein D.L., Heneka M.T., Gavrilyuk V., DelloRusso C., Weinberg G., Galea E. Noradrenergic regulation of inflammatory gene expression in brain. Neurochem. Int. 2002, 41:357-365.
34. Figiel I., Dzwonek K. TNFalpha and TNF receptor 1 expression in the mixed neuronal-glial cultures of hippocampal dentate gyrus exposed to glutamate or trimethyltin. Brain Res. 2007, 1131:17-28.
35. Filliat P., Coubard S., Pierard C., Liscia P., Beracochea D., Four E., Baubichon D., Masqueliez C., Lallement G., Collombet J.M. Long-term behavioral consequences of soman poisoning in mice. Neurotoxicology 2007, 28:508-519.
36. Frijns C.J.M., Kappelle L.J. Inflammatory cell adhesion molecules in ischemic cerebrovascular disease. J. Cereb. Circ. 2002, 33:2115-2122.
37. Fujimoto M., Naka T. Regulation of cytokine signaling by SOCS family molecules. Trends Immunol. 2003, 24:659-666.
38. Ghosh S., May M.J., Kopp E.B. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998, 16:225-260.
39. Grasshoff C., Thiermann H., Antkowiak B. Anaesthesia in patients suffering from organophosphorus intoxication-interactions between general anaesthetics and acetylcholine in cortical networks in vitro. Toxicology 2007, 233:214-222.
40. Hilmas C.J., Williams P.T. Novel mechanism to explain ketamine efficacy against nerve agent induced seizures. Defense Against the Effect of Chemical Hazards: Toxicology, Diagnosis and Medical Countermeasures 2007, 29.21-29.16.
41. Hirayama M., Kuriyama M. MK-801 is cytotoxic to microglia in vitro and its cytotoxicity is attenuated by glutamate, other excitotoxic agents and atropine. Possible presence of glutamate receptor and muscarinic receptor on microglia. Brain Res. 2001, 897:204-206.
42. Jevtovic-Todorovic V., Carter L.B. The anesthetics nitrous oxide and ketamine are more neurotoxic to old than to young rat brain. Neurobiol. Aging 2005, 26:947-956.
43. Johnson E.A., Kan R.K. The acute phase response and soman-induced status epilepticus: temporal, regional and cellular changes in rat brain cytokine concentrations. J. Neuroinflammation 2010, 7:40.
44. Johnson E.A., Dao T.L., Guignet M.A., Geddes C.E., Koemeter-Cox A.I., Kan R.K. Increased expression of the chemokines CXCL1 and MIP-1alpha by resident brain cells precedes neutrophil infiltration in the brain following prolonged soman-induced status epilepticus in rats. J. Neuroinflammation 2011, 8:41.
45. Kawasaki T., Ogata M., Kawasaki C., Ogata J., Inoue Y., Shigematsu A. Ketamine suppresses proinflammatory cytokine production in human whole blood in vitro. Anesth. Analg. 1999, 89:665-669.
46. Kim J.E., Ryu H.J., Yeo S.I., Kang T.C. P2X7 receptor regulates leukocyte infiltrations in rat frontoparietal cortex following status epilepticus. J. Neuroinflammation 2010, 7:65.
47. Kohrs R., Durieux M.E. Ketamine: teaching an old drug new tricks. Anesth. Analg. 1998, 87:1186-1193.
48. Lallement G., Carpentier P., Pernot-Marino I., Baubichon D., Collet A., Blanchet G. Involvement of the different rat hippocampal glutamatergic receptors in development of seizures induced by soman: an autoradiographic study. Neurotoxicology 1991, 12:655-664.
49. Lallement G., Pernot-Marino I., Baubichon D., Burckhart M.F., Carpentier P., Blanchet G. Modulation of soman-induced neuropathology with an anticonvulsant regimen. Neuroreport 1994, 5:2265-2268.
50. Lallement G., Clarencon D., Masqueliez C., Baubichon D., Galonnier M., Burckhart M.F., Peoch H., Mestries J.C. Nerve agent poisoning in primates: antilethal, anti-epileptic and neuroprotective effects of GK-11. Arch. Toxicol. 1998, 72:84-92.
51. Lallement G., Baubichon D., Clarencon D., Galonnier M., Peoch M., Carpentier P. Review of the value of gacyclidine (GK-11) as adjuvant medication to conventional treatments of organophosphate poisoning: primate experiments mimicking various scenarios of military or terrorist attack by soman. Neurotoxicology 1999, 20:675-684.
52. Lang R., Pauleau A.-L., Parganas E., Takahashi Y., Mages J., Ihle J.N., Rutschman R., Murray P.J. SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 2003, 4:546-550.
53. Le Feuvre R.A., Brough D., Touzani O., Rothwell N.J. Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J. Cereb. Blood Flow Metab. 2003, 23:381-384.
54. Lee J.C., Laydon J.T., McDonnell P.C., Gallagher T.F., Kumar S., Green D., McNulty D., Blumenthal M.J., Keys J.R., Land vatter S.W., Strickler J.E., McLaughlin M.M., Siemens I.R., Fisher S.M., Livi G.P., White J.R., Adams J.L., Young P.R. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994, 372:739-746.
55. Lemercier G., Carpentier P., Sentenac-Roumanou H., Morelis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol. (Berl.) 1983, 61:123-129.
56. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2-[Delta][Delta]CT method. Methods 2001, 25:402-408.
57. Matsuo Y., Onodera H., Shiga Y., Nakamura M., Ninomiya M., Kihara T., Kogure K. Correlation between myeloperoxidase-quantified neutrophil accumulation and ischemic brain injury in the rat. Effects of neutrophil depletion. Stroke 1994, 25:1469-1475.
58. Mazar J., Rogachev B., Shaked G., Ziv N.Y., Czeiger D., Chaimovitz C., Zlotnik M., Mukmenev I., Byk G., Douvdevani A. Involvement of adenosine in the antiinflammatory action of ketamine. Anesthesiology 2005, 102:1174-1181.
59. Mazarati A., Liu H., Naylor D., Suchomelova L., Thompson K.W., de Vasconcelos A.P., Sankar R., Nehlig A., Wasterlain C.G. Self-sustaining status epilepticus. Status Epilepticus. Mechanisms and Management 2006, 209-228. The MIT Press, Cambridge, Massachusetts. C.G. Wasterlain, D.M. Treiman (Eds.).
60. McColl B.W., Rothwell N.J., Allan S.M. Systemic inflammatory stimulus potentiates the acute phase and CXC chemokine responses to experimental stroke and exacerbates brain damage via interleukin-1- and neutrophil-dependent mechanisms. J. Neurosci. 2007, 27:4403-4412.
61. McDonough J.H., Shih T.M. Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology. Neurosci. Biobehav. Rev. 1997, 21:559-579.
62. McDonough J.H., Dochterman L.W., Smith C.D., Shih T.M. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicology 1995, 16:123-132.
63. Nakanishi M., Mori T., Nishikawa K., Sawada M., Kuno M., Asada A. The effects of general anesthetics on P2X7 and P2Y receptors in a rat microglial cell line. Anesth. Analg. 2007, 104:1136-1144. (table of contents).
64. Noda M., Nakanishi H., Nabekura J., Akaike N. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J. Neurosci. 2000, 20:251-258.
65. Pantoni L., Sarti C., Inzitari D. Cytokines and cell adhesion molecules in cerebral ischemia: experimental bases and therapeutic perspectives. Arterioscler. Thromb. Vasc. Biol. 1998, 18:503-513.
66. Peinnequin A., Mouret C., Birot O., Alonso A., Mathieu J., Clarencon D., Agay D., Chancerelle Y., Multon E. Rat pro-inflammatory cytokine and cytokine related mRNA quantification by real-time polymerase chain reaction using SYBR green. BMC Immunol. 2004, 5:1471-1480.
67. Pernot F., Heinrich C., Barbier L., Peinnequin A., Carpentier P., Dhote F., Baille V., Beaup C., Depaulis A., Dorandeu F. Inflammatory changes during epileptogenesis and spontaneous seizures in a mouse model of mesiotemporal lobe epilepsy. Epilepsia 2011, 52:2315-2325.
68. Phillips J.B., Williams A.J., Adams J., Elliott P.J., Tortella F.C. Proteasome inhibitor PS519 reduces infarction and attenuates leukocyte infiltration in a rat model of focal cerebral ischemia. Stroke 2000, 31:1686-1693.
69. Ponomarev E.D., Shriver L.P., Dittel B.N. CD40 expression by microglial cells is required for their completion of a two-step activation process during central nervous system autoimmune inflammation. J. Immunol. 2006, 176:1402-1410.
70. Ravizza T., Lucas S.M., Balosso S., Bernardino L., Ku G., Noe F., Malva J., Randle J.C., Allan S., Vezzani A. Inactivation of caspase-1 in rodent brain: a novel anticonvulsive strategy. Epilepsia 2006, 47:1160-1168.
71. Ravizza T., Gagliardi B., Noe F., Boer K., Aronica E., Vezzani A. Innate and adaptive immunity during epileptogenesis and spontaneous seizures: evidence from experimental models and human temporal lobe epilepsy. Neurobiol. Dis. 2008, 29:142-160.
72. Rebenko-Moll N.M., Liu L., Cardona A., Ransohoff R.M. Chemokines, mononuclear cells and the nervous system: heaven (or hell) is in the details. Curr. Opin. Immunol. 2006, 18:683-689.
73. Sairanen T.R., Lindsberg P.J., Brenner M., Carpen O., Siren A.-L. Differential cellular expression of tumor necrosis factor-[alpha] and type I tumor necrosis factor receptor after transient global forebrain ischemia. J. Neurol. Sci. 2001, 186:87-99.
74. Sakai T., Ichiyama T., Whitten C.W., Giesecke A.H., Lipton J.M. Ketamine suppresses endotoxin-induced NF-kappaB expression. Can. J. Anaesth. 2000, 47:1019-1024.
75. Selmaj K.W., Farooq M., Norton W.T., Raine C.S., Brosnan C.F. Proliferation of astrocytes in vitro in response to cytokines. A primary role for tumor necrosis factor. J. Immunol. 1990, 144:129-135.
76. Shibakawa Y., Sasaki Y., Goshima Y., Echigo N., Kamiya Y., Kurahashi K., Yamada Y., Andoh T. Effects of ketamine and propofol on inflammatory responses of primary glial cell cultures stimulated with lipopolysaccharide. Br. J. Anaesth. 2005, 95:803-810.
77. Shih T.M. Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res. 1990, 7:105-116.
78. Shih T.M., McDonough J.H., Koplovitz I. Anticonvulsants for soman-induced seizure activity. J. Biomed. Sci. 1999, 6:86-96.
79. Shih T.M., Duniho S.M., McDonough J.H. Control of nerve agent-induced seizures is critical for neuroprotection and survival. Toxicol. Appl. Pharmacol. 2003, 188:69-80.
80. Shimaoka M., Lida T., Ohara A., Taenaka N., Mashimo T., Honda T., Yoshiya I. Ketamine inhibits nitric oxide production in mouse-activated macrophage-like cells. Br. J. Anaesth. 1996, 77:238-242.
81. Sou J.H., Chan M.H., Chen H.H. Ketamine, but not propofol, anaesthesia is regulated by metabotropic glutamate 5 receptors. Br. J. Anaesth. 2006, 96:597-601.
82. Sparenborg S., Brennecke L.H., Jaax N.K., Braitman D.J. Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman. Neuropharmacology 1992, 31:357-368.
83. Stefini R., Catenacci E., Piva S., Sozzani S., Valerio A., Bergomi R., Cenzato M., Mortini P., Latronico N. Chemokine detection in the cerebral tissue of patients with posttraumatic brain contusions. J. Neurosurg. 2008, 108:958-962.
84. Streit W.J., Kreutzberg G.W. Lectin binding by resting and reactive microglia. J. Neurocytol. 1987, 16:249-260.
85. Streit W.J., Walter S.A., Pennell N.A. Reactive microgliosis. Prog. Neurobiol. 1999, 57:563-581.
86. Svensson I., Waara L., Johansson L., Bucht A., Cassel G. Soman-induced interleukin-1 beta mRNA and protein in rat brain. Neurotoxicology 2001, 22:355-362.
87. Svensson I., Waara L., Cassel G. Effects of HI 6, diazepam and atropine on soman-induced IL-1[beta] protein in rat brain. Neurotoxicology 2005, 26:173-181.
88. Takenaka I., Ogata M., Koga K., Matsumoto T., Shigematsu A. Ketamine suppresses endotoxin-induced tumor necrosis factor alpha production in mice. Anesthesiology 1994, 80:402-408.
89. Testylier G., Lahrech H., Montigon O., Foquin A., Delacour C., Bernabe D., Segebarth C., Dorandeu F., Carpentier P. Cerebral edema induced in mice by a convulsive dose of soman. Evaluation through diffusion-weighted magnetic resonance imaging and histology. Toxicol. Appl. Pharmacol. 2007, 220:125-137.
90. Thomas D.M., Kuhn D.M. MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity. Brain Res. 2005, 190-198.
91. Turowski P., Adamson P., Greenwood J. Pharmacological targeting of ICAM-1 signaling in brain endothelial cells: potential for treating neuroinflammation. Cell. Mol. Neurobiol. 2005, 25:153-170.
92. Vandesompele J., De Preter K., Pattyn F., Poppe B., Van Roy N., De Paepe A., Speleman F. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 2002, 3. (research0034.0031-research0034.0011).
93. Vezzani A., Baram T.Z. New roles for interleukin-1 Beta in the mechanisms of epilepsy. Epilepsy Curr. 2007, 7:45-50.
94. Vezzani A., Conti M., De Luigi A., Ravizza T., Moneta D., Marchesi F., De Simoni M.G. Interleukin-1beta immunoreactivity and microglia are enhanced in the rat hippocampus by focal kainate application: functional evidence for enhancement of electrographic seizures. J. Neurosci. 1999, 19:5054-5065.
95. Vezzani A., Moneta D., Conti M., Richichi C., Ravizza T., De Luigi A., De Simoni M.G., Sperk G., Andell-Jonsson S., Lundkvist J., Iverfeldt K., Bartfai T. Powerful anticonvulsant action of IL-1 receptor antagonist on intracerebral injection and astrocytic overexpression in mice. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:11534-11539.
96. Vezzani A., Moneta D., Richichi C., Aliprandi M., Burrows S.J., Ravizza T., Perego C., DeSimoni M.G. Functional role of inflammatory cytokines and antiinflammatory molecules in seizures and epileptogenesis. Epilepsia 2002, 43:30-35.
97. Wall H.G., McLeod C.G., Hutchison L.S., Shutz M. Brain lesions in rats surviving soman-induced convulsions: light and electron microscopy. Proc. USA Med. Def. Biosci. Rev. 1985, 457-473.
98. Wasterlain C. Inhibition of cerebral protein synthesis by epileptic seizures without motor manifestations. Neurology 1974, 24:175-180.
99. Werner C., Reeker W., Engelhard K., Lu H., Kochs E. Ketamine racemate and S-(+)-ketamine. Cerebrovascular effects and neuroprotection following focal ischemia. Anaesthesist 1997, 46(Suppl 1):S55-S60.
100. Williams A.J., Berti R., Yao C., Price R.A., Velarde L.C., Koplovitz I., Schultz S.M., Tortella F.C., Dave J.R. Central neuro-inflammatory gene response following soman exposure in the rat. Neurosci. Lett. 2003, 349:147-150.
101. Won S.J., Ko H.W., Kim E.Y., Park E.C., Huh K., Jung N.P., Choi I., Oh Y.K., Shin H.C., Gwag B.J. Nuclear factor kappa B-mediated kainate neurotoxicity in the rat and hamster hippocampus. Neuroscience 1999, 94:83-91.
102. Wong D., Prameya R., Dorovini-Zis K. Adhesion and migration of polymorphonuclear leukocytes across human brain microvessel endothelial cells are differentially regulated by endothelial cell adhesion molecules and modulate monolayer permeability. J. Neuroimmunol. 2007, 184:136-148.
103. Yanagisawa N., Morita H., Nakajima T. Sarin experiences in Japan: acute toxicity and long-term effects. J. Neurol. Sci. 2006, 249:76-85.
104. Zimmer L.A., Ennis M., Shipley M.T. Soman-induced seizures rapidly activate astrocytes and microglia in discrete brain regions. J. Comp. Neurol. 1997, 378:482-492.